INSR and neurodegenerative disease: Reduced mRNA and protein levels have been reported in postmortem material from patients with neurodegenerative disorders, for example Alzheimer's sisease [118,153] and Parkinson's disease [119], implying a role for insulin receptor signaling in neurodegenerative diseases.